ICON BIOSCIENCE
IBI is developing a broad portfolio of clinically superior proprietary products, based on its Verisome® drug delivery technology. The company’s initial focus is on its pipeline of reduced-risk, low-cost development programs targeting every major ophthalmic market. IBI’s lead portfolio product, IBI-10090 completed enrollment in its pivotal phase 2/3 clinical trial, in December 2012. An NDA is planned for late 2013. It was founded in 2004 and headquartered in Sunnyvale, California.
ICON BIOSCIENCE
Social Links:
Industry:
Biotechnology Health Care Pharmaceutical
Founded:
2004-01-01
Address:
Sunnyvale, California, United States
Country:
United States
Website Url:
http://www.iconbioscience.com
Total Employee:
11+
Status:
Active
Contact:
650-369-4049
Total Funding:
37.32 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics Apple Mobile Web Clips Icon Google Tag Manager WordPress Google Universal Analytics
Similar Organizations
Arvinas
Arvinas focuses on developing novel therapeutics to treat a variety of diseases including cancer, pro-inflammatory, and autoimmune.
BionPharma
BionPharma develops and commercializes affordable quality generics and builds strong and effective partnerships.
NextWave Pharmaceuticals
NextWave Pharmaceuticals develops and commercializes products utilizing proprietary drug delivery technology.
Souvie Biodelivery
Souvie Biodelivery develops drug delivery services with the goal of marketing novel drug delivery platforms to drug delivery niche markets.
Zogenix
Zogenix develops and commercializes products for the treatment of central nervous system disorders and pain.
Current Employees Featured
Founder
Official Site Inspections
http://www.iconbioscience.com
- Host name: ssdcloudserver.net
- IP address: 162.213.123.219
- Location: Latham United States
- Latitude: 42.747
- Longitude: -73.7527
- Metro Code: 532
- Timezone: America/New_York
- Postal: 12110
